In this study, to uncover the NTRK fusion frequency in the South Korean population with NSCLC, CRC, and inflammatory myofibroblastic tumors (IMT), we performed a pan-Trk IHC assay and confirmed the pan-Trk-positive samples with NGS assays. This evidence concerns the gene TPM3 and inflammatory myofibroblastic tumor.